Abstract
Objectives
To evaluate potential of conventional MRI and diffusion-weighted imaging (DWI) for differentiating malignant from benign peripheral nerve sheath tumors (PNSTs).
Methods
Eighty-seven cases of malignant or benign PNSTs in the trunk or extremities that underwent conventional MRI with contrast enhancement, DWI, and pathologic confirmation between Sep. 2014 and Dec. 2017 were identified. Of these, 55 tumors of uncertain nature on MRI were included. Tumor size, signal, and morphology were reviewed on conventional MRI, and apparent diffusion coefficient (ADC) values of solid enhancing portions were measured from DWI. Patient demographics, MRI features, and ADC values were compared between benign and malignant tumors, and robust imaging findings for malignant peripheral nerve sheath tumors (MPNSTs) were identified using multivariable models.
Results
A total of 55 uncertain tumors consisted of 18 malignant and 37 benign PNSTs. On MRI, tumor size, margin, perilesional edema, and presence of split fat, fascicular, and target signs were significantly different between groups (p < 0.05), as were mean and minimum ADC values (p = 0.002, p < 0.0001). Most inter-reader agreement was moderate to excellent (κ value, 0.45–1.0). The mean ADC value and absence of a split fat sign were identified as being associated with MPNSTs (odds ratios = 13.19 and 25.67 for reader 1; 49.05 and 117.91 for reader 2, respectively). The C-indices obtained by combining these two findings were 0.90 and 0.95, respectively.
Conclusions
Benign and malignant PNSTs showed different features on MRI and DWI. A combination of mean ADC value and absence of split fat was excellent for discriminating malignant from benign PNSTs.
Key Points
• It is important to distinguish between malignant peripheral nerve sheath tumors (MPNSTs) and benign peripheral nerve sheath tumors (BPNSTs) to ensure an appropriate treatment plan.
• On conventional MRI and diffusion-weighted imaging (DWI), MPNSTs and BPNSTs showed significant differences in tumor size, margin, presence of perilesional edema, and absence of split fat, fascicular, and target signs.
• Absence of a split fat sign and mean apparent diffusion coefficient (ADC) values were robust imaging findings distinguishing MPNSTs from BPNSTs, with a C-index of > 0.9.
Similar content being viewed by others
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- AUC:
-
Area under the curve
- BPNSTs:
-
Benign peripheral nerve sheath tumors
- CEFST1WI:
-
Contrast-enhanced fat-suppressed T1-weighted imaging
- DWI:
-
Diffusion-weighted imaging
- MPNSTs:
-
Malignant peripheral nerve sheath tumors
- MRI:
-
Magnetic resonance imaging
- NF-1:
-
Neurofibromatosis type 1
- OR:
-
Odds ratio
- ROC:
-
Receiver operating characteristic
- ROIs:
-
Regions of interest
References
Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT (1999) From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 19:1253–1280
Kransdorf MJ (1995) Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 164:395–402
Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN (2008) Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 97:340–349
Wu JS, Hochman MG (2009) Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 253:297–316
Wasa J, Nishida Y, Tsukushi S et al (2010) MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 194:1568–1574
Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27:124–129
Li CS, Huang GS, Wu HD et al (2008) Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging 32:121–127
Ogose A, Hotta T, Morita T et al (1999) Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol 28:183–188
Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 149:1059–1064
Demehri S, Belzberg A, Blakeley J, Fayad LM (2014) Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience. AJNR Am J Neuroradiol 35:1615–1620
Priola AM, Priola SM, Parlatano D et al (2017) Apparent diffusion coefficient measurements in diffusion-weighted magnetic resonance imaging of the anterior mediastinum: inter-observer reproducibility of five different methods of region-of-interest positioning. Eur Radiol 27:1386–1394
Sung J, Kim JY (2017) Fatty rind of intramuscular soft-tissue tumors of the extremity: is it different from the split fat sign? Skeletal Radiol 46:665–673
Matsumine A, Kusuzaki K, Nakamura T et al (2009) Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol 135:891–900
Mazal AT, Ashikyan O, Cheng J, Le LQ, Chhabra A (2019) Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions. Eur Radiol 29:4123–4132
Iwi G, Millard RK, Palmer AM, Preece AW, Saunders M (1999) Bootstrap resampling: a powerful method of assessing confidence intervals for doses from experimental data. Phys Med Biol 44:N55–N62
Kakkar C, Shetty CM, Koteshwara P, Bajpai S (2015) Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging. Indian J Radiol Imaging 25:453–458
Chee DW, Peh WC, Shek TW (2011) Pictorial essay: imaging of peripheral nerve sheath tumours. Can Assoc Radiol J 62:176–182
Zhao F, Ahlawat S, Farahani SJ et al (2014) Can MR imaging be used to predict tumor grade in soft-tissue sarcoma? Radiology 272:192–201
Crombe A, Marcellin PJ, Buy X et al (2019) Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome. Radiology 291:710–721
Fernebro J, Wiklund M, Jonsson K et al (2006) Focus on the tumour periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis. Sarcoma 2006:1–5
Banks KP (2005) The target sign: extremity. Radiology 234:899–900
Lavdas I, Miquel ME, McRobbie DW, Aboagye EO (2014) Comparison between diffusion-weighted MRI (DW-MRI) at 1.5 and 3 Tesla: a phantom study. J Magn Reson Imaging 40:682–690
Saremi F, Jalili M, Sefidbakht S et al (2011) Diffusion-weighted imaging of the abdomen at 3 T: image quality comparison with 1.5-T magnet using 3 different imaging sequences. J Comput Assist Tomogr 35:317–325
Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B (2011) Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 33:128–135
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Min Hee Lee.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• diagnostic or prognostic study
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yun, J.S., Lee, M.H., Lee, S.M. et al. Peripheral nerve sheath tumor: differentiation of malignant from benign tumors with conventional and diffusion-weighted MRI. Eur Radiol 31, 1548–1557 (2021). https://doi.org/10.1007/s00330-020-07234-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-07234-5